News

LatestNews

OMass Technologies Announces Publication Demonstrating the Impact of Lipid interactions on GPCR Signalling in Nature
July 11, 2018

Oxford, 11 July 2018 – OMass Technologies (“OMass”), a biotechnology company using structural mass spectrometry to drive drug discovery, today announced…

Read More
OMass Technologies secures INNOVATE UK funding in collaboration with the University of Oxford
June 15, 2018

Oxford, 15 June 2017 – OMass Technologies (“OMass”), a biotechnology company using structural mass spectrometry to drive drug discovery, today announced…

Read More